Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.42%726.64B | -4.23%513.92B | -5.78%335.45B | -12.58%154.64B | 1.66%768.24B | -2.26%536.64B | -2.56%356.01B | 0.18%176.9B | 5.09%755.69B | 1.30%549.03B |
| Operating income | -5.42%726.64B | -4.23%513.92B | -5.78%335.45B | -12.58%154.64B | 1.66%768.24B | -2.26%536.64B | -2.56%356.01B | 0.18%176.9B | 5.09%755.69B | 1.30%549.03B |
| Cost of sales | 4.38%-646.08B | ---- | 4.68%-299.69B | ---- | -2.19%-675.64B | ---- | 3.39%-314.41B | ---- | -4.05%-661.14B | ---- |
| Operating expenses | 4.38%-646.08B | 3.70%-457.18B | 4.68%-299.69B | 12.24%-136.78B | -2.19%-675.64B | 2.51%-474.73B | 3.39%-314.41B | 0.13%-155.86B | -4.05%-661.14B | -1.16%-486.97B |
| Gross profit | -13.01%80.56B | -8.35%56.74B | -14.02%35.77B | -15.13%17.86B | -2.06%92.6B | -0.23%61.91B | 4.23%41.6B | 2.48%21.05B | 12.97%94.55B | 2.35%62.05B |
| Selling expenses | -6.73%-3.3B | -2.83%-2.12B | 0.57%-1.39B | 4.59%-690.61M | -21.31%-3.09B | -24.13%-2.07B | -43.78%-1.4B | -43.27%-723.87M | -26.20%-2.55B | -30.88%-1.66B |
| Administrative expenses | 5.94%-42.55B | 10.09%-10.92B | 10.19%-16.98B | 13.93%-3.79B | 4.95%-45.24B | 1.45%-12.14B | -2.97%-18.91B | -3.49%-4.4B | -7.83%-47.59B | -2.27%-12.32B |
| Research and development expenses | ---- | 12.05%-15.34B | ---- | 9.32%-4.25B | ---- | -0.74%-17.44B | ---- | 6.92%-4.69B | ---- | -0.84%-17.31B |
| Profit from asset sales | ---- | -49.65%123.61M | ---- | -49.20%6.68M | ---- | -31.75%245.52M | ---- | 10.58%13.15M | ---- | 116.39%359.75M |
| Revaluation surplus | ---- | -213.25%-451.45M | ---- | 414.77%26.31M | ---- | 79.46%-144.12M | ---- | 110.91%5.11M | ---- | -1,003.46%-701.51M |
| -Changes in the fair value of other assets | ---- | -213.25%-451.45M | ---- | 414.77%26.31M | ---- | 79.46%-144.12M | ---- | 110.91%5.11M | ---- | -1,003.46%-701.51M |
| Impairment and provision | -11.62%-7.86B | -9.03%-3.36B | -10.35%-2.4B | 338.37%520.95M | 10.88%-7.04B | -4.75%-3.08B | 24.15%-2.17B | 125.15%118.84M | 18.84%-7.9B | 15.79%-2.94B |
| -Other impairment is provision | -11.62%-7.86B | -9.03%-3.36B | -10.35%-2.4B | 338.37%520.95M | 10.88%-7.04B | -4.75%-3.08B | 24.15%-2.17B | 125.15%118.84M | 18.84%-7.9B | 15.79%-2.94B |
| Special items of operating profit | 9.69%2.28B | -108.93%-111.86M | 56.83%2.22B | 307.23%32.62M | -15.92%2.08B | 793.37%1.25B | -30.67%1.41B | 94.14%-15.74M | -60.21%2.47B | -89.14%140.26M |
| Adjustment items of operating profit | ---- | ---- | ---- | 0.00%1 | ---- | ---- | ---- | --1 | ---- | ---- |
| Operating profit | -25.90%29.13B | -14.79%22.93B | -16.17%17.21B | -14.54%9.23B | 0.85%39.31B | 2.18%26.91B | 3.97%20.53B | 13.17%10.8B | 14.62%38.97B | -0.43%26.33B |
| Financing income | -5.76%22.85B | 3.36%17.37B | 4.94%11.22B | 12.57%4.12B | 1.44%24.24B | 11.84%16.8B | -3.17%10.7B | 8.81%3.66B | 12.09%23.9B | 24.85%15.03B |
| Financing cost | 5.86%-22.63B | 6.00%-15.61B | 6.09%-10.94B | -2.28%-4.81B | 1.12%-24.04B | -8.59%-16.61B | -1.27%-11.65B | -14.61%-4.7B | -10.95%-24.31B | -8.68%-15.3B |
| Share of profits of associates | 97.19%-13M | ---- | -99.31%2M | ---- | -215.75%-463M | ---- | 33.49%291M | ---- | 16.62%400M | ---- |
| Share of profit from joint venture company | 8.23%-1.73B | ---- | 18.53%-730M | ---- | -33.71%-1.88B | ---- | -25.31%-896M | ---- | -111.56%-1.41B | ---- |
| Special items of earning before tax | ---- | 972.88%201.96M | ---- | 335.34%64.76M | ---- | -88.52%-23.14M | ---- | -190.23%-27.52M | ---- | -120.24%-12.27M |
| Earning before tax | -25.74%27.6B | -10.92%22.79B | -11.62%16.76B | -11.42%8.24B | -1.04%37.16B | 1.09%25.58B | 0.95%18.97B | 9.38%9.3B | 13.49%37.55B | 2.31%25.31B |
| Tax | -3.09%-6.54B | ---- | 9.26%-3.46B | ---- | 0.86%-6.34B | ---- | -18.30%-3.81B | ---- | 10.09%-6.4B | ---- |
| After-tax profit from continuing operations | -31.67%21.06B | -13.26%18.21B | -12.22%13.3B | -10.73%6.72B | -1.07%30.82B | 0.63%20.99B | -2.64%15.16B | 8.44%7.53B | 19.95%31.15B | 5.65%20.86B |
| Adjustment items of earning after tax | ---- | ---1 | ---- | ---1 | ---- | ---- | ---- | ---- | ---- | --1 |
| Earning after tax | -31.67%21.06B | -13.26%18.21B | -12.22%13.3B | -10.73%6.72B | -1.07%30.82B | 0.63%20.99B | -2.64%15.16B | 8.44%7.53B | 19.95%31.15B | 5.65%20.86B |
| Minority profit | -12.95%6.06B | -3.29%4.56B | 5.75%3.31B | -9.66%1.25B | 8.59%6.97B | 5.16%4.72B | -0.63%3.13B | 2.03%1.39B | 11.64%6.41B | 14.78%4.49B |
| Adjustment items of profit attributable to shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1 |
| Profit attributable to shareholders | -37.14%15B | -16.14%13.65B | -16.90%9.99B | -10.98%5.47B | -3.58%23.85B | -0.61%16.27B | -3.15%12.02B | 10.00%6.14B | 22.31%24.74B | 3.39%16.37B |
| Basic earnings per share | -38.57%0.86 | -15.96%0.79 | -17.14%0.58 | -11.11%0.32 | -3.45%1.4 | 0.94 | -4.11%0.7 | 12.50%0.36 | 26.09%1.45 | |
| Diluted earnings per share | -38.57%0.86 | -15.96%0.79 | -17.14%0.58 | -11.11%0.32 | -3.45%1.4 | 0.94 | -4.11%0.7 | 12.50%0.36 | 26.09%1.45 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership), Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.